Specifically, in melanoma Pdcd1l1, the gene encoding Programed Death-Ligand1 (PD-L1), is highly expressed in MDSCs and elevated levels of circulating MDSCs may serve as an indicator of checkpoint inhibition and reduced tumor growth (44–47). The gene discussed is CD274; the disease is melanoma.